Clinical Trial Update: ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial of ABT-751 in children with relapsed or refractory neuroblastoma has completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• ABT-751 (ABT-751)

Snippet

Sponsor: Children's Oncology Group | Conditions: Disseminated Neuroblastoma, Recurrent Neuroblastoma | Phase 2 | Status: COMPLETED | Results posted: 2014-02-28